Followers | 371 |
Posts | 5333 |
Boards Moderated | 1 |
Alias Born | 05/09/2013 |
Thursday, December 01, 2016 2:14:33 PM
This thing has been in similar situations in past 2 years before experiencing short term major recoveries, and also there is data due out in December at anytime yet, which I think most likely will be good (although it is a gamble to speculate).
So given the circumstance of the down 'hole' followers with me are in on APHB so far, I'm going to make the tough decision to add more risk at these new low levels and take a chance on waiting on a recovery in December, rather than abandoning this trade for a large loss.
The time for a stop-loss was at .55+ (which I mistakenly didn't do this time), and so at this point I think it is worth giving this time yet to play out in the short term while averaging down again a 3rd time.
But notably, this is not a standard strategy I apply on my usual trades, doing excessive averaging down on a loss rather than applying a stop-loss, but as already explained, at this point it is a matter of tough choices, and I think that this will most liekly eventually recover higher from today's .40's area, so selling here seems more irrational than instead buying more here.
Based on chart history for volatility, the endured timing of the very low RSI, along with the tight share structure and potential for a short squeeze that could occur at anytime, in addition to other technical factors I apply, I think this trade still has good potential to play out for a profit toward .70+ at least.
1.5 Years saved chart as of 12/01/16 (2:00pm Eastern time):
https://s-media-cache-ak0.pinimg.com/originals/24/75/a7/2475a7a74dee0a87223b0e1ac8ca3334.png
***Go to my 'Profile' for more information on following me***
Recent ARMP News
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/04/2024 10:35:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 09:03:37 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/23/2024 09:17:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:55:39 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:55:01 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:54:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:54:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:54:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:53:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:53:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:53:27 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/15/2023 10:24:56 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/22/2023 11:17:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 12:00:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 11:30:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 11:15:29 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/03/2023 08:35:42 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/03/2023 08:34:24 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 07/24/2023 08:30:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2023 08:30:30 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 07/11/2023 12:27:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2023 12:15:48 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM